Technology Review, of course, is all about the future, and the companies and people involved in the innovation that will get us there. It is in that spirit that we introduce the Technology Review Index, which includes the TR Large-Cap 100 and its sibling, the TR Small-Cap 50. Developed in conjunction with Standard and Poor’s, these global equity indices will serve as our own in-house gauge of the pulse of innovation at 150 of the world’s most important public companies.
Our two indices will track both the most powerful innovators and the up-and-comers in the 10 most innovative industries of the global economy.
Each month, the editors of the magazine will discuss the performance of the Technology Review indices, their constituent industries, and any of their component stocks that stand out in particular. This review should, we think, provide an invaluable reference point for those with a stake in innovation – both today and in the future.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.